Nature Communications (Jul 2023)

Amphetamine disrupts dopamine axon growth in adolescence by a sex-specific mechanism in mice

  • Lauren M. Reynolds,
  • Giovanni Hernandez,
  • Del MacGowan,
  • Christina Popescu,
  • Dominique Nouel,
  • Santiago Cuesta,
  • Samuel Burke,
  • Katherine E. Savell,
  • Janet Zhao,
  • Jose Maria Restrepo-Lozano,
  • Michel Giroux,
  • Sonia Israel,
  • Taylor Orsini,
  • Susan He,
  • Michael Wodzinski,
  • Radu G. Avramescu,
  • Matthew Pokinko,
  • Julia G. Epelbaum,
  • Zhipeng Niu,
  • Andrea Harée Pantoja-Urbán,
  • Louis-Éric Trudeau,
  • Bryan Kolb,
  • Jeremy J. Day,
  • Cecilia Flores

DOI
https://doi.org/10.1038/s41467-023-39665-1
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 22

Abstract

Read online

Abstract Initiating drug use during adolescence increases the risk of developing addiction or other psychopathologies later in life, with long-term outcomes varying according to sex and exact timing of use. The cellular and molecular underpinnings explaining this differential sensitivity to detrimental drug effects remain unexplained. The Netrin-1/DCC guidance cue system segregates cortical and limbic dopamine pathways in adolescence. Here we show that amphetamine, by dysregulating Netrin-1/DCC signaling, triggers ectopic growth of mesolimbic dopamine axons to the prefrontal cortex, only in early-adolescent male mice, underlying a male-specific vulnerability to enduring cognitive deficits. In adolescent females, compensatory changes in Netrin-1 protect against the deleterious consequences of amphetamine on dopamine connectivity and cognitive outcomes. Netrin-1/DCC signaling functions as a molecular switch which can be differentially regulated by the same drug experience as function of an individual’s sex and adolescent age, and lead to divergent long-term outcomes associated with vulnerable or resilient phenotypes.